The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems, providing an alternative to comparator products and lowering price ...
A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals for ...
Gharda CEO Ram Seethapathi outlines how generics reshaped chlorpyrifos — from pricing power to global access — and what it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback